Drugs / Cholecalciferol
last change 10 days ago re-read 9 days ago

Cholecalciferol

Other / unclassified targets NGF, PRODH, VDR via activation

Developed for
vitamin D deficiency · osteoporosis · COVID-19 · type 2 diabetes mellitus · breast cancer · obesity disorder · HIV infectious disease · asthma
+205 more · chronic kidney disease · Crohn disease · end stage renal failure · postmenopausal osteoporosis · systemic lupus erythematosus · polycystic ovary syndrome · prostate cancer · epilepsy · glucose intolerance · heart failure · multiple sclerosis · primary hyperparathyroidism · respiratory tract infectious disorder · sickle cell disease · spinal cord injury · type 1 diabetes mellitus · colorectal cancer · common wart · diabetes mellitus · disorders of vitamin D metabolism · gestational diabetes · pneumonia · pregnancy disorder · prostate adenocarcinoma · pulmonary tuberculosis · secondary hyperparathyroidism · tuberculosis · acute chest syndrome · acute myeloid leukemia · arterial disorder · bone disorder · brain neoplasm · calcinosis · cancer · cardiovascular disorder · chronic obstructive pulmonary disease · depressive disorder · female reproductive system disorder · hepatocellular carcinoma · inflammatory bowel disease · invasive breast carcinoma · leiomyoma · nutritional disorder · osteoarthritis, knee · overactive bladder · schizophrenia · traumatic brain injury · ulcerative colitis · acne · acquired hyperprolactinemia · actinic keratosis · acute bronchiolitis · allergic disease · allergic rhinitis · alopecia areata · angioedema · atherosclerosis · atopic eczema · autism · autism spectrum disorder · Barrett esophagus · basal cell carcinoma · beta-thalassemia major · bipolar depression · blood platelet disease · bronchiectasis · bronchiolitis · bronchitis · cardiovascular-kidney-metabolic syndrome · childhood onset asthma · chronic granulomatous disease · chronic hepatitis C virus infection · chronic pain syndrome · chronic pancreatitis · chronic urticaria · colon adenoma · colon carcinoma · colorectal adenoma · colorectal neoplasm · Coronaviridae infectious disease · cutaneous melanoma · cystic fibrosis · dengue disease · diabetic kidney disease · diabetic neuropathy · diabetic polyneuropathy · diffuse large B-cell lymphoma · disease of bone structure · disease related to hematopoietic stem cell transplant · Down syndrome · dry eye syndrome · ductal breast carcinoma in situ · eclampsia · endocrine pancreas disorder · enuresis · epicondylitis · estrogen-receptor positive breast cancer · female breast carcinoma · female infertility · gingivitis · glioblastoma · HELLP syndrome · hyperbilirubinemia · hyperhomocysteinemia · hyperlipidemia · hyperlipoproteinemia · hypertensive disorder · hypogonadism · idiopathic hypercalciuria · immunodeficiency-related disorder · infectious disease · infectious peritonitis · influenza · iron metabolism disease · lung disorder · malabsorption syndrome · male infertility · malignant pancreatic neoplasm · malposition of teeth with or without hypodontia/oligodontia · melanoma · metabolic bone disorder · metabolic dysfunction-associated steatohepatitis · metabolic syndrome X · metastasis from malignant tumor of colon · mouth disorder · musculoskeletal system disorder · myocardial infarction · NAFLD1 · nasal disorder · nephrotic syndrome · nervous system disorder · nervous system injury · optic neuritis · ovarian cancer · pancreatic neoplasm · periodontal disorder · periodontitis · peripheral arterial disease · peripheral nerve lesion · peripheral neuropathy · polymorphic light eruption · post-COVID-19 disorder · psoriasis · rectal cancer · relapsing-remitting multiple sclerosis · respiratory distress syndrome in premature infants · respiratory failure · rheumatoid arthritis · Rotavirus infection · schizoaffective disorder · seasonal affective disorder · secondary hyperparathyroidism of renal origin · skin cancer · statin toxicity · subjective cognitive decline · sudden sensorineural hearing loss · toxic polyneuropathy · triple-negative breast carcinoma · urinary tract infection · urticaria · uterine corpus leiomyoma · vitiligo · acute respiratory distress syndrome · AIDS · Alzheimer disease · anemia · anemia due to chronic disorder · arthropathy · autoimmune thrombocytopenia · B-cell chronic lymphocytic leukemia · benign paroxysmal positional vertigo · cardio-renal syndrome · chronic transplant rejection · cognitive impairment with or without cerebellar ataxia · congestive heart failure · decubitus ulcer · fetal growth restriction · fibromyalgia · Helicobacter pylori infectious disease · hepatitis C virus infection · inborn error of immunity · infectious disease with sepsis · methicillin-resistant staphylococcus aureus infectious disease · migraine disorder · muscular atrophy · myofascial pain syndrome · myopathy · myositis disease · neonatal sepsis · neurofibromatosis type 1 · neuropathy, painful · obstructive sleep apnea syndrome · overnutrition · Parkinson disease · peritonitis · plantar wart · prediabetes syndrome · preeclampsia · renal osteodystrophy · restless legs syndrome · seasonal allergic rhinitis · secondary hypoparathyroidism due to impaired parathormon secretion · skin disorder · treatment-refractory schizophrenia · vitamin deficiency disorder
Investigated by
Medical University of South Carolina · Medical University of Graz · National Cancer Institute (NCI) · National Heart, Lung, and Blood Institute (NHLBI) · Organon and Co · University of Tromso
+384 more · Alvogen Korea · Brigham and Women's Hospital · National Institute of Allergy and Infectious Diseases (NIAID) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Ain Shams University · Cairo University · Columbia University · Indonesia University · King Faisal Specialist Hospital & Research Center · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh · Case Comprehensive Cancer Center · Emory University · Hanlim Pharm. Co., Ltd. · Hospices Civils de Lyon · Hospital Infantil de Mexico Federico Gomez · Hvidovre University Hospital · Loyola University · Pharmavite LLC · Radboud University Medical Center · Shanghai Jiao Tong University School of Medicine · University Hospital of North Norway · University of Zurich · Zagazig University · Aga Khan University · Andrea Branch · Austrian Science Fund (FWF) · Autoimmunity Centers of Excellence · Baqai Institute of Diabetology and Endocrinology · Canadian Institutes of Health Research (CIHR) · Charite University, Berlin, Germany · Children's Hospital Medical Center, Cincinnati · Children's Hospital of Eastern Ontario · Chuncheon Sacred Heart Hospital · Coordinación de Investigación en Salud, Mexico · Creighton University · Escuela Militar de Graduados de Sanidad, SEDENA · Gary M Brittenham, MD · GlaxoSmithKline · Hartford Hospital · Hospital Regional 1o de Octubre · Johannes Gutenberg University Mainz · Kwang Dong Pharmaceutical co., ltd. · Merck Sharp & Dohme LLC · Ministry of Science and Technology of the People´s Republic of China · National Center for Complementary and Integrative Health (NCCIH) · National Institute on Aging (NIA) · National Institutes of Health (NIH) · National Polytechnic Institute, Mexico · Nîmes University Hospital · Ottawa Hospital Research Institute · Pharma Patent Kft. · Post Graduate Institute of Medical Education and Research, Chandigarh · Roswell Park Cancer Institute · Scotmann Pharmaceuticals · Second Affiliated Hospital of Wenzhou Medical University · Semmelweis University · Seoul National University Hospital · St. Justine's Hospital · Takeda · Tanta University · Thrasher Research Fund · Unity Health Toronto · Universidad Nacional Autonoma de Mexico · University Health Network, Toronto · University Hospital, Angers · University Hospital, Caen · University of Aarhus · University of California, San Francisco · University of Colorado, Denver · University of Liege · University of Minnesota · University of North Carolina, Chapel Hill · University of Oklahoma · all 390 on the full record

Regulatory milestones approvals, filings & regulatory actions · 2 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved EU (EMA) Fosavance — 2005-08-24 europa.eu ↗
Approved US (FDA) INFUVITE ADULT — 2000-05-18 fda.gov ↗

Trials 350 · started per year

today
US approved 2000
EU approved 2005
1
5
2
6
8
21
15
21
39
20
18
11
20
20
18
20
16
19
23
15
11
6
10
4
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 014 trials
Phase 0 NCT07012161 Feb 2025 → Sep 2026 overdue uterine corpus leiomyoma Nahida Akter Recruiting No outcome recorded
Phase 0 NCT06053281 Jan → Dec 2024 epilepsy DINA KEUMALA SARI Unknown No outcome recorded
Phase 0 NCT06539260 Jan 2023 → Jul 2024 immune system disorder, nervous system disorder Suzhou Municipal Hospital of Anhui Province Completed No outcome recorded
Phase 0 NCT05208827 Jan 2022 → Jan 2025 gestational diabetes, nutritional disorder Women's Hospital School Of Medicine Zhejiang University Unknown No outcome recorded
Phase 0 NCT05142072 Dec 2021 → Jan 2022 nasal disorder Deraya University Completed No outcome recorded
Phase 0 NCT04772196 Dec 2020 → Dec 2026 expected — Prisma Health-Midlands Active not recruiting No outcome recorded
Phase 0 NCT04134065 Dec 2019 → Oct 2020 Crohn disease, vitamin D deficiency Nanjing University School of Medicine Unknown No outcome recorded
Phase 0 NCT03028519 Jan 2017 → Dec 2020 ovarian cancer University of Oklahoma Completed No outcome recorded
Phase 0 NCT02936999 Aug 2016 → Jan 2019 female breast carcinoma Inova Health Care Services Terminated No outcome recorded Stop: Business
Phase 0 NCT02172651 Jul 2014 → Apr 2027 expected colon carcinoma, metastasis from malignant tumor of colon Dana-Farber Cancer Institute Recruiting No outcome recorded
Phase 122 trials · 1 met primary
Phase 1 NCT07068282 Jul 2024 → Jan 2025 COVID-19 King Faisal Specialist Hospital & Research Center Completed No outcome recorded
Phase 1 NCT05389943 Jun → Aug 2022 vitamin D deficiency University of Sargodha Unknown No outcome recorded
Phase 1 NCT04844164 Apr 2019 → May 2021 ACTH-dependent Cushing syndrome, acromegaly, primary hyperparathyroidism, type 1 diabetes mellitus Endocrinology Research Centre, Moscow Completed No outcome recorded
Phase 1 NCT03824171 Feb → Mar 2019 osteoporosis Addpharma Inc. Completed No outcome recorded
Phase 1 NCT04120064 Jan 2019 → Dec 2020 vitamin D deficiency Parkview Medical Center Terminated No outcome recorded Stop: Enrollment
Phase 1 NCT03759262 Dec 2018 → May 2020 disease related to hematopoietic stem cell transplant Children's Hospital Los Angeles Completed No outcome recorded
Phase 1 NCT03467789 Oct 2018 → Jan 2023 basal cell carcinoma, nevoid basal cell carcinoma syndrome Case Comprehensive Cancer Center Completed No outcome recorded
Phase 1 NCT03270709 Apr → Oct 2018 HIV infectious disease, vitamin D deficiency Emory University Terminated No outcome recorded Stop: Business
Phase 1 NCT03321318 Jul → Sep 2017 — Alvogen Korea Unknown No outcome recorded
Phase 1 NCT03010267 Jan → Mar 2017 — Alvogen Korea Completed Met primary
Phase 1/211 trials · 1 met primary
Phase 1/2 NCT04244474 Sep → Dec 2019 pneumonia, vitamin D deficiency Cairo University Unknown No outcome recorded
Phase 1/2 NCT05149339 Mar 2019 → Feb 2020 acute myeloid leukemia, vitamin D deficiency Zagazig University Completed No outcome recorded
Phase 1/2 NCT02856503 Jan 2019 → Jan 2023 ductal breast carcinoma in situ, invasive breast carcinoma Eli Avisar, MD Withdrawn No outcome recorded Stop: Business
Phase 1/2 NCT03037593 Jun 2017 → Jun 2020 gestational diabetes University of Minnesota Withdrawn No outcome recorded Stop: Enrollment
Phase 1/2 NCT02099955 Jan 2012 → Dec 2015 spinal cord injury, vitamin D deficiency James J. Peters Veterans Affairs Medical Center Completed No outcome recorded
Phase 1/2 NCT01181193 Mar 2011 → Mar 2013 glioblastoma Soroka University Medical Center Unknown No outcome recorded
Phase 1/2 NCT01375010 Jan 2011 → Feb 2016 HIV infectious disease Columbia University Completed No outcome recorded
Phase 1/2 NCT01276587 Jan → Jun 2011 sickle cell disease Gary M Brittenham, MD Completed No outcome recorded
Phase 1/2 NCT01769625 Jan 2009 → Nov 2016 breast cancer Hartford Hospital Completed No outcome recorded
Phase 1/2 NCT01425476 Jul 2008 → Nov 2016 breast cancer Hartford Hospital Completed No outcome recorded
Phase 281 trials · 4 met primary · 16 missed
Phase 2 NCT07647198 Aug 2026 → Aug 2029 expected leiomyoma Sheikh Shakhbout Medical City Recruiting No outcome recorded
Phase 2 NCT07269457 Mar 2026 → Dec 2028 expected traumatic brain injury Lagos State University Recruiting No outcome recorded
Phase 2 NCT06757244 Feb 2025 → Feb 2028 expected pancreatic neoplasm Hopital Foch Recruiting No outcome recorded
Phase 2 NCT06570200 Oct 2024 → Oct 2025 overdue periodontitis Cairo University Not yet recruiting No outcome recorded
Phase 2 NCT06508099 May 2024 → May 2026 overdue acute biphenotypic leukemia, chronic myeloid leukemia, lymphoblastic lymphoma, myelodysplastic syndrome St. Petersburg State Pavlov Medical University Recruiting No outcome recorded
Phase 2 NCT06101147 Sep 2023 → Apr 2024 polycystic ovary syndrome, vitamin D deficiency Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Completed No outcome recorded
Phase 2 NCT06071481 Jun → Dec 2023 dengue disease Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Unknown No outcome recorded
Phase 2 NCT05269017 Jun 2022 → Mar 2023 — Menoufia University Unknown No outcome recorded
Phase 2 NCT05077813 Dec 2021 → Feb 2022 tuberculosis Kafrelsheikh University Unknown No outcome recorded
Phase 2 NCT04677816 Oct 2021 → Aug 2026 overdue invasive breast carcinoma, triple-negative breast carcinoma, vitamin D deficiency Wake Forest University Health Sciences Recruiting No outcome recorded
Phase 2/316 trials · 3 missed
Phase 2/3 NCT05795933 Apr 2023 → Jun 2024 bronchiolitis Sohag University Completed No outcome recorded
Phase 2/3 NCT05523609 Nov 2022 → Sep 2024 breast cancer Tanta University Unknown No outcome recorded
Phase 2/3 NCT06054919 Apr 2021 → Nov 2023 vitamin D deficiency Indonesia University Unknown No outcome recorded
Phase 2/3 NCT03984890 Aug 2019 → Dec 2021 chronic granulomatous disease Children's Hospital of Fudan University Completed No outcome recorded
Phase 2/3 NCT03602430 Jul → Sep 2018 calcinosis, vitamin D deficiency Ain Shams University Completed No outcome recorded
Phase 2/3 NCT04411901 Mar → Sep 2018 bronchiectasis Heba Omara Completed No outcome recorded
Phase 2/3 NCT02868827 Aug 2017 → Nov 2019 vitamin D deficiency King Abdullah Medical City Terminated No outcome recorded Stop: Enrollment
Phase 2/3 NCT02881957 Oct 2016 → Oct 2018 brain aneurysm, brain neoplasm, epilepsy, intracerebral hemorrhage +4 University of Utah Completed Missed primary
Phase 2/3 NCT02143505 Mar 2014 → Feb 2017 colorectal adenoma Shanghai Jiao Tong University School of Medicine Unknown No outcome recorded
Phase 2/3 NCT01809171 Oct 2013 → Aug 2015 breast cancer, musculoskeletal system disorder Universitaire Ziekenhuizen KU Leuven Terminated No outcome recorded
Phase 367 trials · 6 met primary · 9 missed
Phase 3 NCT07598032 Jun 2026 → Jun 2028 expected prostate adenocarcinoma University of Ilorin Teaching Hospital Not yet recruiting No outcome recorded
Phase 3 NCT03516968 Dec 2023 → Mar 2027 expected obesity disorder Hospices Civils de Lyon Recruiting No outcome recorded
Phase 3 NCT05613192 Oct 2022 → Mar 2023 NAFLD1 Ain Shams University Unknown No outcome recorded
Phase 3 NCT04991324 Sep 2022 → Sep 2024 inflammatory bowel disease University Hospital, Basel, Switzerland Completed No outcome recorded
Phase 3 NCT05417880 Aug 2022 → Feb 2023 type 2 diabetes mellitus Scotmann Pharmaceuticals Unknown No outcome recorded
Phase 3 NCT05270343 Jun 2022 → Jan 2023 type 1 diabetes mellitus Shanghai Jiao Tong University School of Medicine Unknown No outcome recorded
Phase 3 NCT05425914 Nov 2021 → Mar 2022 dry eye syndrome, vitamin D deficiency University of Faisalabad Completed No outcome recorded
Phase 3 NCT05326841 Oct 2021 → Jan 2022 systemic lupus erythematosus Dr Cipto Mangunkusumo General Hospital Completed No outcome recorded
Phase 3 NCT04780061 Jul 2021 → May 2022 COVID-19 The Canadian College of Naturopathic Medicine Terminated Missed primary
Phase 3 NCT04775381 Jun 2021 → Dec 2025 overdue — Hôpital NOVO Recruiting No outcome recorded
Phase 455 trials · 5 met primary · 5 missed
Phase 4 NCT07006714 Sep 2025 → Jul 2027 expected osteoarthritis, vitamin D deficiency University of Miami Active not recruiting No outcome recorded
Phase 4 NCT05758259 Feb → Aug 2023 acne Indonesia University Unknown No outcome recorded
Phase 4 NCT05657678 Dec 2022 → Jan 2026 vitamin D deficiency Uniwersytecki Szpital Kliniczny w Opolu Unknown No outcome recorded
Phase 4 NCT07673497 Sep 2022 → Mar 2023 inflammatory bowel disease, iron metabolism disease, vitamin D deficiency Gazi University Completed No outcome recorded
Phase 4 NCT05276960 Jun 2022 → Aug 2024 cystic fibrosis, osteoporosis, vitamin D deficiency Hospital Infantil de Mexico Federico Gomez Completed No outcome recorded
Phase 4 NCT04952857 Aug → Nov 2021 COVID-19 Post Graduate Institute of Medical Education and Research, Chandigarh Completed Met primary
Phase 4 NCT04739592 Jul 2021 → Jul 2023 osteoarthritis, knee Peking Union Medical College Hospital Unknown No outcome recorded
Phase 4 NCT05216419 Jun 2021 → Oct 2024 vitamin D deficiency Seoul National University Hospital Completed No outcome recorded
Phase 4 NCT04629534 May → Dec 2021 vitamin D deficiency Medical University of South Carolina Terminated No outcome recorded Stop: Enrollment
Phase 4 NCT05591170 Apr → Aug 2021 vitamin D deficiency Department of Endocrinology, Centre of Postgraduate Medical Education Completed No outcome recorded
Phase not applicable84 trials · 2 met primary · 6 missed
— NCT06201013 Apr → Sep 2026 overdue overactive bladder Children's Hospital of Chongqing Medical University Recruiting No outcome recorded
— NCT07053657 Sep → Dec 2025 overdue cardiovascular-kidney-metabolic syndrome Anhui Medical University Recruiting No outcome recorded
— NCT07269223 Sep → Dec 2025 overdue ulcerative colitis University of Veterinary and Animal Sciences, Lahore - Pakistan Recruiting No outcome recorded
— NCT07455656 Aug 2025 → Aug 2026 overdue malposition of teeth with or without hypodontia/oligodontia Al-Azhar University Recruiting No outcome recorded
— NCT07115342 Aug → Oct 2025 overdue allergic rhinitis Tanta University Recruiting No outcome recorded
— NCT07553052 Jun → Aug 2025 HIV infectious disease Universitas Sebelas Maret Completed No outcome recorded
— NCT07045883 Jun 2025 → Jun 2026 overdue sudden sensorineural hearing loss Zhongshan Hospital Xiamen University Active not recruiting No outcome recorded
— NCT07167797 Jan → May 2025 Rotavirus infection University of Baghdad Completed No outcome recorded
— NCT06508333 Dec 2024 → Mar 2025 enuresis Xing Liu Completed No outcome recorded
— NCT06139133 Jan 2024 → Dec 2025 gestational diabetes IIMC, Riphah International University, Pakistan Unknown No outcome recorded
Comparator or background therapy208 trials
Phase 0 NCT07861464 Comparator Jan 2025 → Jul 2026 benign paroxysmal positional vertigo University of Jordan Completed No outcome recorded
Phase 0 NCT06073925 Comparator Dec 2023 → Jul 2024 autoimmune thrombocytopenia Mansoura University Unknown No outcome recorded
Phase 0 NCT02337257 Comparator Apr 2014 → Sep 2015 periodontitis, vitamin D deficiency Augusta University Unknown No outcome recorded
Phase 1 NCT06515548 Comparator Aug 2024 → Feb 2025 — Cairo University Completed No outcome recorded
Phase 1 NCT06565728 Comparator Nov 2022 → May 2023 fetal growth restriction Cairo University Completed No outcome recorded
Show all 208 trials opens the full record — a long page

News releases announcing trial results or a regulatory action · 1

DateIssuerRelease
2020-03-25 OPKO Health, Inc. Results OPKO Health Reports Interim Results for Two Ongoing RAYALDEE Studies opko.com ↗
The mean iPTH reduction observed so far with RAYALDEE has exceeded 25% from pre-treatment baseline.

Evidence & citations 38 cited values

Every value below carries the sentence it was read from. 577 sources stand behind the page.

FieldValueCited text
Known as cholecalciferol “The investigators hypothesise that supplementation of vitamin D3 (Cholecalciferol), in addition to standard antibiotic and other supportive therapy in the management of...” NCT02185196 ↗
324

“Genotype 1 or 4 HCV-infected patients with null response to previous PegIFN/RBV treatment and with hypovitaminosis D (< 30 ng/mL) prospectively received cholecalciferol 100000...” PMID 25987791 ↗ May 2015

“Neonates were given vitamin D3 (cholecalciferol) in an oral drops formulation (400 IU/drop), at a dose of 400 IU once a day until the serum bilirubin level was out of...” NCT07098234 ↗

“Participants with deficient levels of vitamin D will receive vitamin D supplementation at the initiation of chemotherapy with 50,000 IU of oral vitamin D3 (cholecalciferol)...” NCT04677816 ↗

“A new fixed-dose combination (FDC) formulation of raloxifene 60 mg and cholecalciferol 800 IU was developed to improve the medication compliance and overall efficacy of...” PMID 36247744 ↗ Sep 2022

“To investigate the effect of cholecalciferol (vitamin D3) supplementation on peripheral immune cell frequency and N-glycan branching in patients with relapsing-remitting...” PMID 32830462 ↗ Aug 2020

“vitamin D will be obtained from a commercial product in the Egyptian pharmacies called (Devarol S) in the form of injectable ampoules containing 200000 IU of cholecalciferol (2.5 mg/ml)” NCT06570200 ↗

“vitamin D3 (Cholecalciferol), vitamin D3 obtained from 2 ml vials containing 200,000 IU each (Devarol- S- 200.000 I.U. produced by Memphis. for Pharmaceutical and Chemical Industries)” NCT04244474 ↗

“The patients received oral liquid cholecalciferol supplementation (OsteVit DTM, Key Pharmaceuticals, Macquarie Park, NSW, Australia), supplied in 50 mL bottles (5000 units in 1 mL).” NCT04134065 ↗

“Deficient volunteers (Vit-D serum <30 ng/mL) were assigned (V1) to receive either 100,000 IU/15 days of cholecalciferol (D, n = 19), or a placebo (P, n = 19), over a 3 month period.” PMID 30800121 ↗ Feb 2019

“will receive supplementary Vitamin D3(NIVAGEN Vitamin D3 Cholecalciferol 50000 IU) oral once weekly for 3 months as adjuvant therapy in combination with their treatment for ITP.” NCT06073925 ↗

Show 314 more sources

Known as 1,25 dihydroxycholecalciferol “1,25 dihydroxycholecalciferol (vitamin D3) is the most active hormonal form of vitamin D.” NCT07455656 ↗
Known as 1,25 Dihydroxyvitamin D3 “Effects of Vitamin D3 (1,25 Dihydroxyvitamin D3) on Pharmacokinetics and Absorption of Folic Acid and Fexofenadine in Healthy Volunteers” NCT01856348 ↗
Known as 25-Hydroxyvitamin D “Cholecalciferol (25-Hydroxyvitamin D)” NCT00798993 ↗
Known as A11CC05 Colecalciferol “A11CC05 Colecalciferol” NCT01721915 ↗
1

“A11CC05 Colecalciferol” NCT01748370 ↗

Known as BABY D3 “Vitamin D3 as "BABY D3"” NCT01287455 ↗
Known as cholecalciferol (vitamin D) “cholecalciferol (vitamin D)” NCT01769625 ↗
1

“cholecalciferol (Vitamin D)” NCT01425476 ↗

Known as cholecalciferol (vitamin D3) “cholecalciferol (vitamin D3)” NCT02172651 ↗
Known as colecalciferol “Vitamin D3 (cholecalciferol, colecalciferol) is one of type of vitamin D which is made by the skin when exposed to sunlight; it is also found in some foods and can be taken as...” NCT01472445 ↗
16

“Alendronic acid 70mg with Colecalciferol 70mcg” NCT03006003 ↗

“30,000 IU vitamin D (colecalciferol)” NCT04840238 ↗

“Colecalciferol 16.800 IU per week” NCT02122627 ↗

“Vitamin D3 ( Colecalciferol)” NCT06690723 ↗

“Vitamin D3 ( Colecalciferol)” NCT01264874 ↗

“A11CC05 Colecalciferol” NCT01748370 ↗

NCT01075022 ↗

NCT00504946 ↗

NCT01339676 ↗

NCT01432704 ↗

Show 6 more sources

Known as Colecalciferol, cholecalciferol, vitamin D3 “Colecalciferol, cholecalciferol, vitamin D3” NCT02122627 ↗
Known as Dekristol “Once weekly treatment with peroral colecalciferol capsules (Dekristol®, Swiss-Caps, Switzerland) containing 20 mg of colecalciferol corresponding to 20000 IU or 0.5 mg of vitamin D” NCT01339676 ↗
Known as Devarol “vitamin D3 (an aqueous preparation of cholecalciferol (Devarol® ampoule 200 000 IU/2 ml, Memphis, Egypt)” NCT06327581 ↗
Known as Devarol S “The aqueous solution of vitamin D3 is used (Devarol S 200,000IU/2ml ) 0.6 ml (60,000 IU ) will be slowly injected into the base of the largest wart” NCT07196670 ↗
Known as Devarol- S- 200.000 I.U. “vitamin D3 (Cholecalciferol), vitamin D3 obtained from 2 ml vials containing 200,000 IU each (Devarol- S- 200.000 I.U. produced by Memphis. for Pharmaceutical and Chemical Industries)” NCT04244474 ↗
Known as Enteral Vit-D 3 “Patients will receive Enteral Vit-D 3 (cholecalciferol) supplementation.” NCT07813975 ↗
Known as IM vitamin D3 - Inj Arachitol (Solvay, India) “IM vitamin D3 - Inj Arachitol (Solvay, India)” NCT00956839 ↗
Known as inactive vitamin D “Cholecalciferol (inactive vitamin D)” NCT04145492 ↗
Known as NIVAGEN Vitamin D3 “will receive supplementary Vitamin D3(NIVAGEN Vitamin D3 Cholecalciferol 50000 IU) oral once weekly for 3 months as adjuvant therapy in combination with their treatment for ITP.” NCT06073925 ↗
Known as Oral vitamin D3 - Tab Cipcal (Cipla, India) “Oral vitamin D3 - Tab Cipcal (Cipla, India)” NCT00956839 ↗
Known as OsteVit DTM “The patients received oral liquid cholecalciferol supplementation (OsteVit DTM, Key Pharmaceuticals, Macquarie Park, NSW, Australia), supplied in 50 mL bottles (5000 units in 1 mL).” NCT04134065 ↗
Known as Sunny D (Vitamin D3) Softgel Capsule “Sunny D™ (Vitamin D3) Softgel Capsule” NCT05080530 ↗
Known as TillVal-D “cholecalciferol (TillVal-D)” NCT00893451 ↗
Known as TillVal-D, cholecalciferol, vitamin D3 “TillVal-D, cholecalciferol, vitamin D3” NCT00893451 ↗
Known as UVEDOSE “The drug evaluated is vitamin D3 (cholecalciferol), administered in the form of oral solution (2 mL) containing 100,000 IU, manufactured by the laboratory CRINEX and marketed...” NCT03475225 ↗
1

“vitamin D3 supplementation (UVÉDOSE®, cholecalciferol, 100 000 IU drinkable solution, 2 ml vial)” NCT01480869 ↗

Known as V drops “Patients will receive vitamin D drug with generic name: V drops manufactured by Medical Union Pharmaceuticals, Egypt Dosage form: liquid drops Dosage, frequency, and...” NCT02550912 ↗